Literature DB >> 20672309

Simultaneous color-coded imaging to distinguish cancer "stem-like" and non-stem cells in the same tumor.

Atsushi Suetsugu1, Yosuke Osawa, Masahito Nagaki, Hisataka Moriwaki, Shigetoyo Saji, Michael Bouvet, Robert M Hoffman.   

Abstract

In this study, we demonstrate that the differential behavior, including malignancy and chemosensitivity, of cancer stem-like and non-stem cells can be simultaneously distinguished in the same tumor in real time by color-coded imaging. CD133(+) Huh-7 human hepatocellular carcinoma (HCC) cells were considered as cancer stem-like cells (CSCs), and CD133(-) Huh-7 cells were considered as non-stem cancer cells (NSCCs). CD133(+) cells were isolated by magnetic bead sorting after Huh-7 cells were genetically labeled with green fluorescent protein (GFP) or red fluorescent protein (RFP). In this scheme, CD133(+) cells were labeled with GFP and CD133(-) cells were labeled with RFP. CSCs had higher proliferative potential compared to NSCCs in vitro. The same number of GFP CSCs and the RFP NSCCs were mixed and injected subcutaneously or in the spleen of nude mice. CSCs were highly tumorigenic and metastatic as well as highly resistant to chemotherapy in vivo compared to NSCCs. The ability to specifically distinguish stem-like cancer cells in vivo in real time provides a visual target for prevention of metastasis and drug resistance.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20672309     DOI: 10.1002/jcb.22792

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Linking stem cells to chromosomal instability.

Authors:  Karel H M van Wely; Carlos Martínez-A
Journal:  Oncoimmunology       Date:  2012-03-01       Impact factor: 8.110

Review 2.  In vivo molecular and single cell imaging.

Authors:  Seongje Hong; Siyeon Rhee; Kyung Oh Jung
Journal:  BMB Rep       Date:  2022-06       Impact factor: 5.041

3.  Sirolimus and MMF are insufficient immunosuppressants for regulation of the proliferation of CD133+EpCAM+ cell populations in HCC cell lines.

Authors:  Hwajung Kim; Kwang-Woong Lee; Seung Cheol Oh; Min-Young Park; Sooin Seo; Xue-Li Jin; Suk Kyun Hong; Kyung Chul Yoon; Nam-Joon Yi; Kyung-Suk Suh
Journal:  Biomed Rep       Date:  2020-10-20

4.  Sutureless Surgical Orthotopic Implantation Technique of Primary and Metastatic Cancer in the Liver of Mouse Models.

Authors:  Hiroto Nishino; Hannah M Hollandsworth; Norihiko Sugisawa; Jun Yamamoto; Yoshihiko Tashiro; Sachiko Inubushi; Kazuyuki Hamada; Y U Sun; Hyein Lim; Siamak Amirfakhri; Filemoni Filemoni; Robert M Hoffman; Michael Bouvet
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 5.  Application of GFP imaging in cancer.

Authors:  Robert M Hoffman
Journal:  Lab Invest       Date:  2015-02-16       Impact factor: 5.662

6.  Comparison of tumor biology of two distinct cell sub-populations in lung cancer stem cells.

Authors:  Jianyu Wang; Zhiwei Sun; Yongli Liu; Liangsheng Kong; Shixia Zhou; Junlin Tang; Hongmei Rosie Xing
Journal:  Oncotarget       Date:  2017-06-13

7.  Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells.

Authors:  Pietro Carotenuto; Somaieh Hedayat; Matteo Fassan; Vincenzo Cardinale; Andrea Lampis; Vincenza Guzzardo; Caterina Vicentini; Aldo Scarpa; Luciano Cascione; Daniele Costantini; Guido Carpino; Domenico Alvaro; Michele Ghidini; Francesco Trevisani; Robert Te Poele; Massimiliano Salati; Sofia Ventura; Georgios Vlachogiannis; Jens C Hahne; Luke Boulter; Stuart J Forbes; Rachel V Guest; Umberto Cillo; Ian Said-Huntingford; Ruwaida Begum; Elizabeth Smyth; Vasiliki Michalarea; David Cunningham; Lorenza Rimassa; Armando Santoro; Massimo Roncalli; Vladimir Kirkin; Paul Clarke; Paul Workman; Nicola Valeri; Chiara Braconi
Journal:  Hepatology       Date:  2020-09-10       Impact factor: 17.425

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.